Microvision (NASDAQ:MVIS) Stock, Quote.Headers.trade-ideas

Microvision

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

News

Penny Stocks

Markets

Analyst Ratings

Tech

Trading Ideas

LITE

MVIS

For Immediate Release

Chicago, IL – May 20, 2024 – Today, Zacks Equity Research discusses Lumentum Holdings and MicroVision.

Industry: Laser Systems

Zacks Industry Outlook Highlights Lumentum and MicroVision

Macro,Shot,Of,Computer,Monitor,With,World,Stock,Market,Chart

Intraday Update

Movers

ACIC

ADMA

AEHL

AFRM

AKAM

ARRY

ARWR

BFRI

BROS

CDNA

CLNE

DCBO

DIOD

EVLV

FLNC

FLUX

FNKO

FROG

FWRD

GRPN

GRTS

GWAV

HGAS

INSG

IOVA

ITOS

LIDR

MGNX

MLTX

NGVC

NTRA

NVAX

NVTS

ORGO

OUST

PEGY

PGNY

RVNC

RWAY

SKIN

SKYT

SOUN

SRTS

YELP

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

image12

Pre-Market Outlook

AAOI

CREV

LIPO

Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Microvision Inc

WIIM

ADTN

AIRE

ATGL

BIGC

CIEN

COHR

COMM

DMRC

FLEX

FORM

KEYS

NSSC

OLED

ONDS

OPTX

PSTG

SHOP

SMRT

TIXT

UBXG

ZBRA

Shares of companies within the broader tech sector are trading higher amid overall market strength following strong US economic data that could help ease recession concerns. The sector may be experiencing momentum in sympathy with Cisco Systems after the company reported better-than-expected Q4 financial results.

MicroVision shares are trading higher after the company reported better-than-expected Q2 financial results.

Microvision shares are trading higher after the company reported better-than-expected Q2 financial results.

Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. The company reported quarterly sales of $1.900 million which beat the analyst consensus estimate of $1.100 million by 72.73 percent. This is a 477.51 percent increase over sales of $329.000 thousand the same period last year.

Earnings

Earnings Beats

Microvision Q2 2024 GAAP EPS $(0.11) Beats $(0.12) Estimate, Sales $1.900M Beat $1.100M Estimate

WestPark Capital analyst Kevin Garrigan reiterates Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) with a Hold.

Reiteration

5WestPark Capital Reiterates Hold on Microvision

Cantor Fitzgerald analyst Andres Sheppard reiterates Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) with a Neutral and maintains $3 price target.

Price Target

Cantor Fitzgerald Reiterates Neutral on Microvision, Maintains $3 Price Target

ABTS

ARQQ

BLND

CFLT

CXDO

ENPH

INFY

MOVE

NTRP

OKTA

SOBR

TROO

WULF

Shares of companies within the broader technology sector are trading higher amid overall market strength as investors assess this week's inflation data.

<h3>For Immediate Release</h3>
Chicago, IL &ndash; May 20, 2024 &ndash; Today, Zacks Equity Research discusses Lumentum Holdings and MicroVision.
Industry: Laser Systems
The Zacks Laser Systems and Components industry is suffering from challenging macroeconomic conditions globally, weak economic conditions in Europe and a sluggish economic environment in China. Continued economic uncertainty with low PMI numbers in Europe, North America and Japan is impacting industrial demand and capital investments.
However, industry participants like Lumentum Holdings&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lite#NASDAQ">LITE</a>) and MicroVision (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvis#NASDAQ">MVIS</a>) benefit from upbeat demand from electric vehicles, electronics, semiconductors and healthcare end-markets. Robust demand for high-power continuous wave and pulsed laser for cutting and battery-processing applications, growing demand for high-performance optical devices, and the ongoing proliferation of Generative AI, cloud computing, autonomous driving, IoT and 5G are the key catalysts.
<h3>Industry Description</h3>
The Zacks Laser Systems and Components industry comprises companies offering high-performance fiber lasers, fiber amplifiers and diode lasers, optical and photonic products, and scanning technology solutions. The key end markets are semiconductors, metrology, advanced communication and medical devices. Industry participants also provide high-precision 3D sensors and system products for inspection and metrology.
Moreover, in the medical devices space, laser and other energy-based aesthetic treatments can achieve therapeutic results by affecting structures within the skin. Developing safe and effective aesthetic treatments has resulted in a well-established market for these procedures. The industry also operates in the cyclical surface mount technology and semiconductor capital equipment markets.
<h3>3 Laser Systems &amp; Components Industry Trends to Watch</h3>
Emerging Applications Driving Demand for Lasers: The industry is benefiting from increasing demand for emerging applications like additive manufacturing, facial recognition, gesture recognition, LiDAR applications and IoT. Advanced lasers, especially those with 3D sensing (3DS) capabilities, are enhancing interactions using technology. Notably, 3DS &mdash; the technology that allows users to create 3D printable objects, control games with body gestures and measure objects &mdash; is in high demand.
Laser-IoT Combination Supports Efficiency: As industries are increasingly adopting automation techniques, combining lasers with IoT improves operating efficiency. IoT-supported manufacturing equipment is far easier to update with firmware. The combination reduces costs and increases the flexibility and reliability manifold by enabling material-handling capabilities through remote sources. Strong demand from semiconductor and allied markets, which are seeing a rapid shift toward the production of micro and nano devices, is another positive for industry participants.
Challenging Macroeconomic Condition Hurts Prospect: Industry participants suffer from sluggish capital spending by original equipment manufacturers. Moreover, persistent inflation, energy headwinds in Europe and weakness in China are expected to hurt industry participants in the near term.
<h3>Zacks Industry Rank Indicates Dim Prospects</h3>
The Zacks Laser Systems and Components industry is housed within the broader Zacks Computer and Technology sector. It carries a Zacks Industry Rank #240, which places it in the bottom 4% of more than 250 Zacks industries.
The group&#39;s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates bearish near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.
Despite the lackluster outlook, there are a few stocks worth watching in the industry. But before we present the top industry picks, it is worth looking at the industry&#39;s shareholder returns and current valuation first.
<h3>Industry Underperforms Broader Sector and S&amp;P 500</h3>
The Zacks Laser Systems and Components industry has underperformed the broader Zacks Computer and Technology sector and the S&amp;P 500 composite over the past year.
The industry has declined 27.3% over this period against the S&amp;P 500&#39;s rise of 26.4% and the broader sector&#39;s growth of 39.3%.
<h3>Industry&#39;s Current Valuation</h3>
On the basis of the trailing 12-month P/S, which is a commonly used multiple for valuing Laser Systems and Components stocks, we see that the industry is currently trading at 6.36X compared with the S&amp;P 500&#39;s 4.06X. It is also trading above the sector&#39;s trailing 12-month P/S of 5.51X.
Over the last five years, the industry has traded as high as 12.64X and as low as 3.96X, with a median of 6.34X.
<h3>2 Laser Stocks to Watch</h3>
Lumentum: This San Jose, CA-based company benefits from an expanding portfolio. Its innovative product pipeline, which includes new 1.6 terabit intra-data center optical transceivers, optical switching products, and 800G coherent pluggables, is expected to improve its footprint in the data center interconnect market.
Lumentum&#39;s expanding manufacturing capacity is expected to help it address cloud customers&#39; strong demand. A strong partner base is noteworthy.
LITE shares have lost 10.7% year to date. The Zacks Consensus Estimate for this Zacks Rank #3 (Hold) company&#39;s fiscal 2024 earnings has declined 7.5% to 99 cents per share over the past 30 days.
MicroVision: Redmond, WA-based MicroVision is a well-known provider of MEMS-based solid-state automotive lidar technology and ADAS solutions. The stock has declined 54.7% in the year-to-date period.
MicroVision benefits from a diversified portfolio. It offers multiple technology nodes, with highest resolutions, smallest form factor LiDAR with its MEMS-based long-range MAVIN, as well as small form factor short-range sequential flash-based MOVIA LiDAR product lines.
The Zacks Consensus Estimate for MVIS&#39; 2024 loss has been unchanged at 49 cents per share in the past 30 days. MicroVision currently has a Zacks Rank #3.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed&nbsp;that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and&nbsp;is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&amp;P 500 is an unmanaged index.
<a href="https://www.zacks.com/stock/news/2275785/zacks-industry-outlook-highlights-lumentum-and-microvision?cid=CS-BENZ-FT-press_releases-2275785">To read this article on Zacks.com click here.</a>

<h3>Gainers</h3>
<ul>
<li>Maxeon Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) stock increased by 17.4% to $2.9 during Tuesday's pre-market session. The company's market cap stands at $153.0 million. </li>
<li>AMTD Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) stock moved upwards by 16.25% to $4.22. The company's market cap stands at $806.8 million. </li>
<li>Rubicon Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBT#NYSE">RBT</a>) shares rose 10.55% to $0.26. The company's market cap stands at $13.6 million. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock rose 10.49% to $2.21. The market value of their outstanding shares is at $13.1 million. </li>
<li>Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) stock increased by 9.6% to $1.37. The company's market cap stands at $283.1 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) shares moved upwards by 8.79% to $0.58. The market value of their outstanding shares is at $55.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) shares declined by 9.8% to $18.4 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.3 billion. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>Alpha Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) shares fell 9.67% to $3.88. The company's market cap stands at $59.2 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) shares declined by 8.44% to $2.17. The market value of their outstanding shares is at $8.2 million. </li>
<li>TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) shares decreased by 7.59% to $2.07. The market value of their outstanding shares is at $625.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock decreased by 6.83% to $2.32. The market value of their outstanding shares is at $15.0 million. The company's, Q1 earnings came out today. </li>
<li>BigCommerce Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIGC#NASDAQ">BIGC</a>) stock fell 5.85% to $7.25. The company's market cap stands at $560.2 million. As per the press release, Q1 earnings came out 3 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

JAMF

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

QMCO

SLNH

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Shares of Diodes Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIOD#NASDAQ">DIOD</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/DIOD/earnings">quarterly financial results</a>.
Diodes posted adjusted earnings of 28 cents per share, missing market estimates of 31 cents per share. The company's quarterly sales came in at $301.97 million missing expectations of $305.01 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Diodes shares dipped 9.8% to $68.99 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares jumped 139% to $10.73 after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and develop COVID-influenza combination vaccines.</li>
<li>iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) gained 40% to $17.06 after the company announced a $120 million registered direct offering and reported Q1 financial results.</li>
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) shares climbed 39.8% to $1.65 after the company disclosed a partnership with LITEON Technology Corporation.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) shares climbed 39.4% to $32.86 after the company reported better-than-expected first-quarter sales results.</li>
<li>Ouster, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) gained 34.3% to $13.90 after the company reported better-than-expected first-quarter financial results.</li>
<li>Organogenesis Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>) rose 32% to $3.02 following upbeat quarterly results.</li>
<li>Inseego Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) gained 31.4% to $5.05 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates.</li>
<li>CareDx, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) surged 26.3% to $13.99 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>Sensus Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) shares rose 22.5% to $4.6699 after the company reported better-than-expected first-quarter financial results.</li>
<li>Groupon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) gained 22.3% to $12.85 after the company reported better-than-expected first-quarter results.</li>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) jumped 21.8% to $1.90 after the company reported better-than-expected quarterly GAAP EPS results.</li>
<li>ADMA Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) rose 21% to $8.39 after the company reported better-than-expected first-quarter financial results and issued strong revenue guidance.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares gained 19.3% to $5.66 in pre-market trading after the company reported better-than-expected first quarter financial results.</li>
<li>American Coastal Insurance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) rose 17.2% to $12.79 after the company reported better-than-expected first quarter financial results. The company announced the sale of 100% of its issued and outstanding stock of Interboro Insurance Company to Forza Insurance Holdings.</li>
<li>Global Gas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGAS#NASDAQ">HGAS</a>) rose 15.3% to $1.28.</li>
<li>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) gained 15% to $23.42 after the company reported better-than-expected quarterly earnings and authorized a $3 billion share repurchase program.</li>
<li>Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) gained 14.6% to $1,478.49 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) rose 14.4% to $7.61.</li>
<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) climbed 13.6% to $2.74 following upbeat quarterly results.</li>
<li>Natural Grocers by Vitamin Cottage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGVC#NASDAQ">NGVC</a>) gained 13.2% to $20.19 following second-quarter results.</li>
<li>Natera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) rose 11.3% to $106.36 following strong first-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) jumped 11% to $6.50 following first-quarter results.</li>
<li>Integral Ad Science Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) gained 8.8% to $9.12 after the company reported better-than-expected first-quarter sales results and issued FY24 revenue guidance above estimates.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) jumped 8.7% to $35.68 after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $33 to $46.</li>
<li>Funko Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) gained 7% to $7.30 as the company reported better-than-expected first-quarter earnings and issued strong earnings forecast for the second quarter. The company also appointed Cynthia Williams as its Chief Executive Officer, effective May 20.</li>
<li>Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) gained 6.8% to $34.26 after the company reported better-than-expected first-quarter financial results and raised its FY24 EPS range.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) shares rose 3.5% to $12.94 after the company reported stronger-than-expected financial results for the first quarter on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) shares fell 73.4% to $3.9089 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) fell 37.2% to $0.0439 after jumping 20% on Thursday.</li>
<li>Flux Power Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) dipped 35.8% to $2.9350 after the company reported worse-than-expected quarterly financial results.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) fell 29.3% to $1.30 after the company announced second half and full year 2023 financial results.</li>
<li>Evolv Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) fell 29.2% to $2.7290 after the company reported worse-than-expected first-quarter financial results and lowered its FY24 sales guidance below estimates.</li>
<li>Revance Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) fell 27% to $3.0950 as the company posted a loss for its first quarter on Thursday.</li>
<li>Biofrontera Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) fell 26.6% to $1.16.</li>
<li>American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) dipped 22.2% to $9.84 following weak quarterly results.</li>
<li>UTime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) dipped 22% to $0.25.</li>
<li>The Beauty Health Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKIN#NASDAQ">SKIN</a>) fell 22% to $2.80 following quarterly results.</li>
<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) shares fell 21.6% to $1.27 after the company reported worse-than-expected first-quarter GAAP EPS results.</li>
<li>Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) shares fell 21.5% to $25.51 after the company reported worse-than-expected first-quarter sales results and issued FY24 sales guidance below estimates.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares declined 20.7% to $0.0579 after the company reported worse-than-expected first quarter financial results.</li>
<li>The E.W. Scripps Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) dipped 19.7% to $3.71 following quarterly results.</li>
<li>CS Disco, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAW#NYSE">LAW</a>) fell 19.6% to $6.50 following weak sales.</li>
<li>Safe and Green Development Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGD#NASDAQ">SGD</a>) shares fell 18.4% to $0.6937 after jumping around 37% on Thursday.</li>
<li>Docebo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) fell 18.2% to $37.99.</li>
<li>JFrog Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares fell 17.7% to $33.43 after the company reported first quarter financial results.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) shares fell 17.3% to $0.7606 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) fell 15.6% to $11.35 following first-quarter financial results.</li>
<li>Gritstone bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) shares declined 14.4% to $0.8320 after the company reported worse-than-expected first quarter GAAP EPS results.</li>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares fell 12.8% to $4.0850 after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) declined 12.2% to $14.72.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) fell 11.1% to $21.97 after the company reported second-quarter financial results.</li>
<li>AMN Healthcare Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMN#NYSE">AMN</a>) fell 9.5% to $55.08 following first-quarter results.</li>
<li>Evolent Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) fell 8.4% to $24.69 after the company reported first-quarter financial results.</li>
<li>Akamai Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) fell 8.1% to $94.16 after the company issued weak guidance.</li>
<li>Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) declined 7.8% to $17.28 following second-quarter financial results.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) dipped 7.4% to $3.3399.</li>
<li>MoonLake Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) fell 7% to $39.02.</li>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) fell 5% to $33.13. BMO Capital analyst James Fotheringham maintained Affirm with a Market Perform and lowered the price target from $48 to $46.</li>
<li>Runway Growth Finance Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RWAY#NASDAQ">RWAY</a>) shares fell 4.1% to $11.61 as the company priced its secondary offering of 3.75 million common stock by selling stockholder at $11.50 per share.</li>
<li>Yelp Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) shares declined 3.6% to $38.20 after the company reported a first-quarter revenue miss.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38760794/bitcoin-tops-63-000-akash-network-emerges-as-top-gainer">Bitcoin Tops $63,000; Akash Network Emerges As Top Gainer</a>

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock rose 59.6% to $1.92 during Friday's regular session. The company's market cap stands at $12.4 million. </li>
<li>Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) stock rose 32.55% to $5.09. The company's market cap stands at $60.4 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) shares moved upwards by 24.83% to $12.92. The market value of their outstanding shares is at $582.1 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) stock moved upwards by 15.09% to $23.41. The market value of their outstanding shares is at $14.9 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) stock increased by 13.37% to $7.54. The market value of their outstanding shares is at $356.9 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>LightPath Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTH#NASDAQ">LPTH</a>) shares rose 11.27% to $1.48. The company's market cap stands at $56.2 million. As per the news, the Q3 earnings report came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Evolv Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) shares declined by 37.5% to $2.4 during Friday's regular session. The company's market cap stands at $373.3 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) shares fell 24.39% to $1.23. The market value of their outstanding shares is at $252.4 million. The company's, Q1 earnings came out yesterday. </li>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) stock fell 24.05% to $1.04. The market value of their outstanding shares is at $91.2 million. </li>
<li>JFrog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares decreased by 16.92% to $33.75. The market value of their outstanding shares is at $3.6 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>CS Disco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAW#NYSE">LAW</a>) stock declined by 16.73% to $6.72. The company's market cap stands at $407.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>Issuer Direct (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ISDR#AMEX">ISDR</a>) shares fell 14.93% to $10.2. The market value of their outstanding shares is at $38.9 million. As per the press release, Q1 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ISDR

LPTH

12 Information Technology Stocks Moving In Friday's Intraday Session

Shares of Natera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) rose sharply in today's pre-market trading following strong first-quarter earnings.
Natera posted GAAP loss of 56 cents per share, compared to market expectations for a loss of 71 cents per share. The company's quarterly sales came in at $367.700 million versus estimates of $316.306 million.
Natera, shares jumped 15.3% to $110.25 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) gained 165% to $11.84 in pre-market trading after the company reported first-quarter results.</li>
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) gained 38.1% to $1.63 in pre-market trading after the company disclosed a partnership with LITEON Technology Corporation.</li>
<li>Sensus Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) shares rose 26.3% to $4.8110 in pre-market trading after the company reported better-than-expected first-quarter financial results.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) shares gained 18.7% to $27.98 in pre-market trading after the company reported better-than-expected first-quarter sales results.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) rose 15.3% to $11.07 in today's pre-market trading after declining around 10% on Thursday.</li>
<li>Inseego Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) gained 15.3% to $4.43 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) shares rose 12.7% to $14.11 in pre-market trading after the company reported stronger-than-expected financial results for the first quarter on Thursday.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares gained 13.3% to $5.38 in pre-market trading after the company reported better-than-expected first quarter financial results.</li>
<li>Funko Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) gained 11.9% to $7.63 in pre-market trading as the company reported better-than-expected first-quarter earnings and issued strong earnings forecast for the second quarter. The company also appointed Cynthia Williams as its Chief Executive Officer, effective May 20.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) shares dipped 64.5% to $5.20 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
<li>Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) shares fell 36% to $20.80 pre-market trading after the company reported worse-than-expected first-quarter sales results and issued FY24 sales guidance below estimates.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) dipped 27.8% to $0.0505 in pre-market trading after jumping 20% on Thursday.</li>
<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) shares fell 27.2% to $1.18 in pre-market trading after the company reported worse-than-expected first-quarter GAAP EPS results.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares declined 23.3% to $0.0560 in pre-market trading after the company reported worse-than-expected first quarter financial results.</li>
<li>Lipella Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) shares fell 20% to $0.60 in pre-market trading.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) shares dipped 16.4% to $8.79 in pre-market trading after the company issued weak second-quarter guidance.</li>
<li>Safe and Green Development Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGD#NASDAQ">SGD</a>) shares fell 14.8% to $0.7225 in pre-market trading after jumping around 37% on Thursday..</li>
<li>JFrog Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares fell 13.4% to $35.10 in pre-market trading after the company reported first quarter financial results.</li>
<li>Gritstone bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) shares declined 13.2% to $0.8449 in pre-market trading after the company reported worse-than-expected first quarter GAAP EPS results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/24/05/38753453/investor-sentiment-improves-further-dow-jumps-over-300-points">Investor Sentiment Improves Further, Dow Jumps Over 300 Points</a>

<h3>Gainers</h3>
<ul>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock rose 36.7% to $1.64 during Friday's pre-market session. The market value of their outstanding shares is at $10.6 million. </li>
<li>Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) shares increased by 16.66% to $4.48. The company's market cap stands at $53.2 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>WiSA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) stock moved upwards by 16.44% to $3.54. The company's market cap stands at $11.3 million. </li>
<li>SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) stock rose 14.1% to $5.42. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares moved upwards by 13.9% to $0.45. The company's market cap stands at $44.1 million. </li>
<li>Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) shares increased by 9.17% to $11.3. The market value of their outstanding shares is at $509.1 million. The company's, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) shares fell 25.9% to $1.2 during Friday's pre-market session. The market value of their outstanding shares is at $247.2 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Evolv Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) stock declined by 19.02% to $3.11. The company's market cap stands at $483.8 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) stock decreased by 14.05% to $9.06. The company's market cap stands at $350.8 million. The company's, Q1 earnings came out yesterday. </li>
<li>JFrog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares fell 13.81% to $35.01. The market value of their outstanding shares is at $3.7 billion. The company's, Q1 earnings came out yesterday. </li>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) stock fell 13.31% to $0.73. The market value of their outstanding shares is at $200.0 million. </li>
<li>Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares decreased by 10.45% to $4.2. The company's market cap stands at $768.8 million. As per the press release, Q1 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

WISA

XTKG

12 Information Technology Stocks Moving In Friday's Pre-Market Session

MicroVision shares are trading lower after the company reported worse-than-expected Q1 GAAP EPS results.

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.
Shares of Akamai Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) fell sharply in today's pre-market trading after the company issued <a href="https://www.benzinga.com/quote/AKAM/earnings">weak guidance</a>.
The company said it sees FY24 adjusted EPS of $6.20 to $6.40 compared to market estimates of $6.73. It expects revenue of $3.95 billion to $4.02 billion, versus expectations of $4.08 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Akamai Technologies shares dipped 10.4% to $91.73 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) shares tumbled 64.5% to $5.20 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
<li>Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) shares declined 36% to $20.80 pre-market trading after the company reported worse-than-expected first-quarter sales results and issued FY24 sales guidance below estimates.</li>
<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) shares declined 27.2% to $1.18 in pre-market trading after the company reported worse-than-expected first-quarter GAAP EPS results.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) shares declined 16.4% to $8.79 in pre-market trading after the company issued weak second-quarter guidance.</li>
<li>JFrog Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares dipped 13.4% to $35.10 in pre-market trading after the company reported first quarter financial results.</li>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares fell 10.4% to $4.20 in pre-market trading after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) shares fell 10.4% to $0.8243 in pre-market trading after the company reported worse-than-expected first-quarter sales results.</li>
<li>indie Semiconductor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) shares dipped 9.2% to $5.26 in pre-market trading following weak quarterly results.</li>
<li>Yelp Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) shares declined 7.1% to $36.80 pre-market trading after the company reported a first-quarter revenue miss.</li>
<li>Runway Growth Finance Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RWAY#NASDAQ">RWAY</a>) shares fell 6.1% to $11.37 in pre-market trading as the company priced its secondary offering of 3.75 million common stock by selling stockholder at $11.50 per share.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38753455/enbridge-funko-and-3-stocks-to-watch-heading-into-friday">Enbridge, Funko And 3 Stocks To Watch Heading Into Friday</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

INDI

Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 18.18 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $956.000 thousand which beat the analyst consensus estimate of $750.000 thousand by 27.47 percent. This is a 22.25 percent increase over sales of $782.000 thousand the same period last year.

Earnings Misses

Microvision Q1 2024 GAAP EPS $(0.13) Misses $(0.11) Estimate, Sales $956.000K Beat $750.000K Estimate

<h3>Gainers</h3>
<ul>
<li>Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) shares rose 5.0% to $0.6 during Friday's after-market session. The market value of their outstanding shares is at $59.3 million. </li>
<li>Arqit Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) shares moved upwards by 4.99% to $0.52. The company's market cap stands at $85.5 million. </li>
<li>Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) stock moved upwards by 4.99% to $1.68. The market value of their outstanding shares is at $328.0 million. </li>
<li>NextNav (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NN#NASDAQ">NN</a>) shares moved upwards by 4.99% to $7.78. The company's market cap stands at $875.6 million. </li>
<li>Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) stock moved upwards by 4.98% to $11.79. The market value of their outstanding shares is at $452.7 million. </li>
<li>Expensify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) stock moved upwards by 4.89% to $1.5. The company's market cap stands at $127.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>OMNIQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMQS#NASDAQ">OMQS</a>) stock decreased by 3.9% to $0.5 during Friday's after-market session. The market value of their outstanding shares is at $5.3 million. </li>
<li>One Stop Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSS#NASDAQ">OSS</a>) shares decreased by 3.84% to $3.01. The company's market cap stands at $62.3 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) stock decreased by 3.49% to $0.44. The market value of their outstanding shares is at $2.2 million. </li>
<li>T Stamp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) stock declined by 3.09% to $0.93. The market value of their outstanding shares is at $9.8 million. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) stock declined by 2.78% to $1.4. The market value of their outstanding shares is at $80.8 million. </li>
<li>XTI Aerospace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) shares decreased by 2.59% to $3.01. The company's market cap stands at $29.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKTS

ARBK

EXFY

IDAI

MYSZ

OMQS

XTIA

12 Information Technology Stocks Moving In Friday's After-Market Session

Warning: MVIS is at high risk of performing badly

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Offloading <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> to avoid can effectively shield your portfolio from downside risk.&nbsp; Though the stock market&rsquo;s been on a breathtaking run of late, with potential interest rate cuts on the horizon, not all investment opportunities are worth wagering on.



With the bullishness in the stock market, it&rsquo;s perhaps an opportune time to rotate back into penny stocks to buy. However,&nbsp;it is important not to get ahead of ourselves and avoid penny stocks lacking solid fundamentals.&nbsp;



Hence, the current economic optimism needs to be tempered with a more strategic approach prioritizing quality and stability. This cautiousness is imperative in avoiding the pitfalls of high-risk penny stock bets.



That said, here are three penny stocks to avoid. These stocks have a history of high volatility and consistent unprofitability. Moreover, these businesses have struggled to demonstrate financial stability and continue to post hefty losses, making their stock prices prone to major fluctuations.



<h2>Penny Stocks To Avoid: Microvision (MVIS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/06/mvis1600-2-300x169.png" alt="Self Driving Autopilot Car Technologies, Radar, 360, Sensor, Cameras, Laser. Artificial Intelligence Digitalizes and Analyzes Road. Sensor Scanning Road Ahead for Vehicles, Danger, Speed Limits. Lidar, MVIS stock"><div>Source: mpohodzhay / Shutterstock.com</div></div>Once a scanning technology firm, Microvision (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvis-stock-quote/">MVIS</a>) shifted to lidar technology during the pandemic in hopes of revitailizing its business.&nbsp;



Four years into its transformation, though, Microvision has barely scratched the surface, failing to make any major inroads with the top automotive players. Consequently, it burns through truckloads of cash each quarter, relying on continuous at-the-market (ATM) offerings to fund operations. On top of that, the lidar space is capital-intensive, demanding colossal investment in research and development.&nbsp;



Hence, without meaningful revenue growth, it&rsquo;s unlikely that MVIS stock can survive for much longer. It <a href="https://seekingalpha.com/news/4104041-microvision-gaap-eps-of-0_13-misses-0_01-revenue-of-0_96m-beats-0_21m?source=content_type%3Areact%7Csection%3Asummary%7Csection_asset%3Aall_news%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A4">posted a measly $960,000 in sales </a>in its first-quarter (Q1), while posting a whopping $26.3 million in net losses.



Additionally, it utilized $20.8 million in cash during Q1, more than $7 million higher than the prior year. Hence, the financial strain is evident, making it unlikely for the firm to turn things around potentially. As a result, MVIS stock is down an eye-watering 67% year-to-date (YTD) and more than 23% in the past month alone, with no comeback in sight.



<h2>Plug Power (PLUG)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/12/plug1600-2-300x169.png" alt="Person holding smartphone with logo of US hydrogen fuel cell company Plug Power Inc. (PLUG) on screen in front of website. Focus on phone display. Unmodified photo."><div>Source: T. Schneider / Shutterstock.com</div></div>Plug Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/plug-stock-quote/">PLUG</a>)&nbsp;finds itself at a critical juncture as it looks to navigate the topsy-turvy hydrogen fuel cell industry. Its top-line growth is under duress, with the general slowdown in the EV space and diminishing enthusiasm for renewable energy investments. To complicate things further, there&rsquo;s the issue of the timing of electrolyzer deployments and the inherent seasonality in its niche.



Its recent financial results shed light on its struggles, with sales plummeting 43% year-over-year (YOY) in <a href="https://seekingalpha.com/filing/8645215?source=content_type%3Areact%7Csection%3Aearnings_summary%7Csection_asset%3Aearnings_history%7Cfirst_level_url%3Asymbol%7Cbutton%3Afiling-10-Q">Q1 from $210.3 million</a> to just $120.3 million. This led to an escalation in net losses to a whopping $295.8 million, or 46 cents per share. Also, its fixed-price hydrogen supply contracts have backfired for the company as rising hydrogen costs force sales at a loss, weighing down its margins.



Despite its best efforts to turn the tide by producing low-cost &ldquo;green hydrogen,&rdquo; the company faces a long and winding road to recovery. Hence, its best to avoid PLUG stock at this time.



<h2>Skillz (SKLZ)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/sklz-1600-300x169.png" alt="Skillz (SKLZ) company logo on a website"><div>Source: Dennis Diatel / Shutterstock.com</div></div>Skillz is an online gaming platform that took off during the pandemic with its skill-based competitions, offering real-money prizes. However, the post-pandemic scenario has been incredibly harsh for its business. The platform is grappling with rising customer acquisition costs and needs to keep its users engaged. These fundamental problems led to negative revenue growth for the past eight consecutive quarters, with the company surpassing top-line estimates only once during this period.



Q1 was particularly bleak, with a 43.2% YOY drop in net losses to $26.7 million. Even its go-to metric, the <a href="https://seekingalpha.com/news/4104233-skillz-gaap-eps-of-145-revenue-of-252m">average revenue per paying user (ARPPMA)</a>, barely budged, inching up just seven cents to $69.8 from the prior-year period. Hence, these numbers underscore the challenges facing Skillz in its efforts to stabilize and grow its business in a competitive market.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the&nbsp;date of publication, Muslim Farooque did not have (either&nbsp;directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>
<div>Muslim Farooque is a keen investor and an optimist at heart. A life-long gamer and tech enthusiast, he has a particular affinity for analyzing technology stocks. Muslim holds a bachelor&rsquo;s of science degree in applied accounting from Oxford Brookes University.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/06/pump-and-dump-3-penny-stocks-to-avoid-like-the-plague/">Pump-and-Dump: 3 Penny Stocks to Avoid Like the Plague</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Pump-and-Dump: 3 Penny Stocks to Avoid Like the Plague

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
When does a growth stock become one of the top <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a> to avoid?



It sounds like the beginning of a riddle or a bad joke, but the answer is obvious &ndash; it&rsquo;s when the stock is deceptive and tricks you into believing that it can be a good buy. You look at the Portfolio Grader and get interested because a stock has a good grade specifically for growth, but then realize that it still has an &ldquo;F&rdquo; rating overall.



How can that happen?



The Portfolio Grader rates stocks based on earnings history, growth, analyst sentiment and momentum. The growth grade in particular is a popular metric for finding growth stocks to avoid.



But it&rsquo;s also important to see why a company is getting a good growth grade. Because sometimes, looking at a single factor like growth can be misleading and can&rsquo;t make up for the company&rsquo;s deficiencies in other areas.



Today, we&rsquo;re going to look at several companies that have good growth grades, and we&rsquo;ll investigate why that&rsquo;s happening in each case. But then we&rsquo;ll pull back the curtain, look at the fuller picture, and explore why these growth stocks to avoid are still getting &ldquo;F&rdquo; grades overall.



In the end, an exercise like this is a good reminder to not rely on any one metric when considering your stock portfolio. Growth is highly desirable, but the growth stocks to avoid on this list can easily drag your portfolio into the gutter.



<h2>Virgin Galactic (SPCE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/03/spce1600-300x169.jpg" alt="Virgin Galactic (SPCE) billboard on the New York Stock Exchange, across from the Fearless Girl statue. aerospace stocks"><div>Source: Tun Pichitanon / Shutterstock.com</div></div>It makes sense to jump right into one of the growth stocks to avoid that&rsquo;s been a huge disappointment &ndash; and has cost plenty of investors a lot of money along the way. 



Virgin Galactic (NYSE:<a href="https://investorplace.com/stock-quotes/spce-stock-quote/">SPCE</a>) made its name in the billionaire space race as founder Richard Branson competed with SpaceX and Blue Orgin to see which would be the first to make it into space with a civilian crew. 



You may remember that Virgin Galactic won that race, as it shot Branson into suborbital flight just a few days before Jeff Bezos did the same on a Blue Orgin rocket.



But honestly, that&rsquo;s the high point for this company. Space tourism doesn&rsquo;t feel any closer today than it did several years ago, and few people have the several hundred thousand dollars it takes to make the trip, even if the flights become a reality.



Virgin Galactic has burned through more than $1 billion in the last two years and rewarded investors with a 93% fall in stock price. SPCE recently completed a <a href="https://investorplace.com/2024/06/will-a-1-for-20-reverse-split-save-virgin-galactic-spce-stock/">1-for-20 reverse stock split</a> to push the price back over the Nasdaq threshold and maintain listing compliance, but the reality is that this is a bad stock and a weak company.



SPCE stock shows an &ldquo;A&rdquo; rating for growth in the Portfolio Grader because its revenue was up 410% in the last quarter. But sales of only $1.99 million show that people aren&rsquo;t lining up to ride a <a href="https://seekingalpha.com/article/4690417-virgin-galactic-holdings-inc-spce-q1-2024-earnings-call-transcript?source=content_type%3Areact%7Csection%3ATranscripts%7Csection_asset%3ATranscripts%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A2">Delta rocket</a> into space as early as 2026, which is the company&rsquo;s latest projections.



SPCE stock gets an &ldquo;F&rdquo; rating overall in the Portfolio Grader.



<h2>Helius Medical Technologies (HSDT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/tech1600a-300x169.jpg" alt="Image of hand touching globe with a city in the background, implying connectivity"><div>Source: Shutterstock</div></div>Helius Medical Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/hsdt-stock-quote/">HSDT</a>) is a neurotech company headquartered in eastern Pennsylvania. The company makes medical devices that help people with balance and gait issues without getting a neurological implant. It is also one of the growth stocks to avoid in the space.



The company&rsquo;s devices improve the brain&rsquo;s ability to compensate for deficiencies and rehabilitate lost brain function. For instance, its Portable Neuromodulation Stimulator stimulates the brain through nerves in the tongue. 



It&rsquo;s being used as a short-term treatment to help people with multiple sclerosis symptoms. But it&rsquo;s an expensive device, priced at more than $23,000.



The company saw <a href="https://ir.heliusmedical.com/news-releases/news-release-details/helius-medical-technologies-inc-reports-first-quarter-2024">revenue grow</a> in the first quarter, giving it a decent growth grade in the Portfolio Grader. But we&rsquo;re still not looking at a lot of money. Revenue in the first quarter was $135,000, versus $111,000 in the same quarter a year ago.



It posted a net loss of $2.5 million, the same as a year ago. The earnings per share loss of $3.08 was better than the loss of $4.22 per share from Q1 2023.



HSDT stock is down 87% this year. It has an &ldquo;A&rdquo; rating for growth but an &ldquo;F&rdquo; rating overall in the Portfolio Grader.



<h2>InMed Pharmaceuticals (INM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-1-1-300x169.jpg" alt="cannabis stocks"><div>Source: Shutterstock</div></div>InMed Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/inm-stock-quote/">INM</a>) is a Canadian company that is a clinical-stage pharmaceutical company that&rsquo;s working to develop cannabis-infused treatments for Alzheimer&rsquo;s disease, vision and skin conditions.



The company is attempting to develop an effective pipeline of drug candidates targeting CB1 and CB2 receptors. 



Its attempt to develop an anti-itch skin cream is in Phase 2 testing, and it is seeking a partnership to help it develop the product. Its other pipeline candidates for Alzheimer&rsquo;s and dry age-related macular degeneration are in preclinical trials.



Developing new therapies is an expensive undertaking and a challenge for investors because the company has to spend a lot of cash on research and development without seeing income for years, if ever.



For the third fiscal quarter of 2024 (ending March 31), InMed reported a net loss of $5.7 million. The company saw sales of $1.1 million, up slightly from a year ago, and a gross profit of $289,000, which was better than its profit of $192,511 in the same quarter a year ago.



The profit increase helps InMed&rsquo;s growth grade in the Portfolio Grader. Still, the company also acknowledges that it has money only to finance research and development into the fourth calendar quarter of 2024. That is a worrisome disclosure.



INM stock gets a &ldquo;B&rdquo; rating for growth but an &ldquo;F&rdquo; rating overall in the Portfolio Grader. The stock is down 36% this year.



<h2>P3 Health Partners (PIII)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/healthcare1600a-300x169.jpg" alt="stethoscope on a stock chart representing healthcare stocks to buy. Healthcare Stocks"><div>Source: Shutterstock</div></div>P3 Health Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/piii-stock-quote/">PIII</a>) is a health management company that supports providers with administrative services and coordination for their Medicare Advantage patients.



The company currently operates in Arizona, Oregon, Nevada, Florida and California, with a network of more than 2,900 primary care providers.



It recently announced raising <a href="https://ir.p3hp.org/news-events/press-releases/detail/106/p3-health-partners-inc-announces-approximately-42-2">$42.2 million</a> through the sale of 67.4 million units of stock with institutional investors, valued at just over 62 cents per share. That will give the company an infusion of cash to operate, but it also serves to dilute the share base.



First-quarter financial results included $388.5 million in revenue, up 29% from a year ago. But gross profits fell from $16.5 million to $6.4 million, and the company reported a net loss of $49.6 million.



PIII is among the growth stocks to avoid in part because it is down 62% this year. It gets an &ldquo;A&rdquo; rating for growth, but still has an &ldquo;F&rdquo; rating overall in the Portfolio Grader.



<h2>Sunshine Biopharma (SBFM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600-300x169.jpg" alt="Illustration of a biopharma company. Doctor standing in front of various medical icons."><div>Source: Billion Photos / Shutterstock</div></div>Sunshine Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/sbfm-stock-quote/">SBFM</a>) is a Florida-based biopharma company developing potential treatments in oncology and antivirals.



Thanks to its ownership of a Canadian pharmacy, Nora Pharma, which distributes generic medications, Sunshine was able to show <a href="https://sunshinebiopharma.com/wp-content/uploads/20240521_SBFM-Press-Release-Reports-Q1_2024_.pdf">sales</a> of $7.5 million in the first quarter, a gain from $4.8 million a year ago. That gives it a solid grade for growth in the Portfolio Grader.



However, Sunshine is a long path to ever bringing its own drugs to market, and that&rsquo;s where the real money is made. Sunshine is currently testing a Covid-19 treatment in mice at the University of Arizona in hopes of developing a treatment for patients who cannot use Paxlovid, Molnupiravir or Remdisivir.



It has a second drug candidate, to treat cancer, ready for testing on mice as well. However, the company&rsquo;s third drug candidate, also a cancer drug, is on hold after lab tests did not yield a favorable result.



The Nora Pharma sales weren&rsquo;t enough to help Sunshine generate a profit for the quarter, either. It posted a net loss of $1.2 million versus a loss of $1.7 million in the first quarter of 2023.



SBFM stock is down 98% this year. It gets an &ldquo;A&rdquo; rating for growth but an &ldquo;F&rdquo; rating overall in the Portfolio Grader.



<h2>MicroVision (MVIS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/06/mvis1600-300x169.png" alt="Autonomous Self Driving Car Moving Through highway - Animated Scanning Visualization Concept of Artificial Intelligence Digitalizes and Analyzes Road Using Lidar. MVIS stock"><div>Source: aslysun / Shutterstock.com</div></div>With more vehicles on the road these days than ever, the advances in driver-assisted technology are pretty interesting. MicroVision (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvis-stock-quote/">MVIS</a>) makes automotive lidar sensors to help driver-assistance systems and autonomous vehicles function.



The company&rsquo;s sensors are also used in industrial, smart infrastructure and robotics.



It gets a good grade for growth in the Portfolio Grader because the company increased its revenue in the first quarter, bringing in $956,000 versus $782,000 in the first quarter of 2023. That&rsquo;s a healthy percentage increase that helps give it an &ldquo;A&rdquo; grade for growth.



But then look closer. MicroVision lost <a href="https://ir.microvision.com/news/press-releases/detail/402/microvision-announces-first-quarter-2024-results">$26.3 million in the quarter</a>, versus a loss of $19 million in the same quarter a year ago. When you&rsquo;re losing that much money, an $174,000 increase in revenue doesn&rsquo;t help that much.



MVIS stock is down 59% this year. Despite its &ldquo;A&rdquo; grade for growth, MicroVision gets an &ldquo;F&rdquo; rating overall in the Portfolio Grader.



<h2>Predictive Oncology (POAI)</h2>



<a href="https://investorplace.com/wp-content/uploads/2024/02/artificial-intelligence-ai-brain-tech-1600-768x432-1.jpg"><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/artificial-intelligence-ai-brain-tech-1600-768x432-1-300x169.jpg" alt="A concept image representing AI (artificial intelligence)."></a>Predictive Oncology (NASDAQ:<a href="https://investorplace.com/stock-quotes/poai-stock-quote/">POAI</a>) is working to harness the power of artificial intelligence to help bring drugs to market. The company believes that AI can help reduce the time it takes to successfully test and manufacture a drug, and is working specifically on cancer therapies.



The company has a biobank of&nbsp;<a href="https://predictive-oncology.com/biobankai/">150,000 tumor tissue samples</a>&nbsp;and uses machine learning to help it test and discover successful molecules. It also uses AI for drug development and for clinical trials.



And it saw an uptick in revenue in the first quarter, bringing in $419,000 versus $239,000 in the first quarter of 2023.



But the company also posted a loss of $4.2 million and $1.04 per share, versus a loss of $3.4 million and 86 cents per share in the same quarter a year ago.



That&rsquo;s why POAI stock is getting an &ldquo;A&rdquo; rating for growth but an &ldquo;F&rdquo; rating overall in the Portfolio Grader. The stock is down 67% this year.



On the date of publication, neither Louis&nbsp;Navellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/market360/2024/06/7-f-rated-growth-stocks-to-avoid-right-now-june-2024/">7 F-Rated Growth Stocks to Avoid Right Now: June 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 F-Rated Growth Stocks to Avoid Right Now: June 2024

Microvision (MVIS) has provided an announcement. MicroVision, Inc.'s CEO, Sumit Sharma, has entered into a new employment agreement that maintains ...

Microvision CEO Sumit Sharma Secures New Employment Deal

Microvision GAAP EPS of -$0.11 beats by $0.02, revenue of $1.9M beats by $0.9M

MicroVision, Inc. 2024 Q2 - Results - Earnings Call Presentation

MicroVision, Inc. (MVIS) Q2 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Holograms are no longer limited to the screens of Star Trek; they are here and now, with uses ranging from movies and computer games to medicine and automotive. As innovations have made holographic displays more realistic, engaging and interactive, they are expected to find new applications in numerous industries. This leads to my list of the best holographic display stocks to buy.



While virtual reality (VR) and augmented reality (AR) are still relatively new technologies, they are gradually integrating with the latest holographic technologies, thus opening new ways of interacting with customers. The holographic display <a href="https://www.gminsights.com/industry-analysis/holographic-display-market">market</a> is expected to grow tremendously and be valued at over 23 billion by 2032. This growth is attributed to increasing demand for (haptic) feedback for entertainment, medical imaging and vehicle dashboard tasks.



Thus, the right choice of holographic display stocks to invest in can be a key factor in this fast-paced environment. Here are three companies to consider.



<h2>MicroVision (MVIS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/06/mvis1600-2-300x169.png" alt="Self Driving Autopilot Car Technologies, Radar, 360, Sensor, Cameras, Laser. Artificial Intelligence Digitalizes and Analyzes Road. Sensor Scanning Road Ahead for Vehicles, Danger, Speed Limits. Lidar, MVIS stock"><div>Source: mpohodzhay / Shutterstock.com</div></div>MicroVision (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvis-stock-quote/">MVIS</a>) is a technology company that has attracted investors&rsquo; interest in holographic displays and augmented reality. Therefore, it is a stock that could be of interest to investors keen on investing in these technologies.&nbsp;



PicoP <a href="https://ir.microvision.com/news/press-releases/detail/59/microvision-to-showcase-the-capabilities-of-its-picop">scanning</a> technology is the company&rsquo;s main asset. This technology uses lasers to project images and information. It is useful in several industries, including automotive lidar systems, augmented reality and consumer electronics.&nbsp;



Over the last few years, Microvision has concentrated on developing lidar sensors for self-driving cars and other ADAS applications. Their long-range lidar solution aims to provide high-resolution, real-time 3D sensing capabilities, which is crucial for self-driving cars.



MVIS could be one of the best holographic display stocks for investors. Its market cap of just 186.39 million suggests it has plenty of upside potential.



<h2>Vuzix (VUZI)</h2>



<a href="https://investorplace.com/wp-content/uploads/2018/02/vuzi.png"><img width="185" height="185" src="https://investorplace.com/wp-content/uploads/2018/02/vuzi.png" alt="An image of the logo for Vuzix Corp (VUZI)."></a>Vuzix (NASDAQ:<a href="https://investorplace.com/stock-quotes/vuzi-stock-quote/">VUZI</a>) is an important company in the industry of wearable display technologies and augmented reality. This makes it a good stock for investors interested in the holographic display market.



Vuzix designs and manufactures wearable display devices, mainly smart glasses and AR solutions. Their leading products are the M-Series and Blade smart glasses, the former targeted at the enterprise market and the latter for the consumer market. These devices place a heads-up display (HUD) of digital information on top of the user&rsquo;s view of the physical world. These glasses have various use cases, as seen in the healthcare, logistics and manufacturing industries.&nbsp;



VUZI is a buy because of its <a href="https://stockanalysis.com/stocks/vuzi/statistics/">valuation</a>. Its market cap is just $64 million at the time of writing. Meanwhile, it has caught the attention of Wall Street analysts, with an implied upside of over 200%.



<h2>Sony (SONY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/sony_sne_1600-300x169.jpg" alt="Sony logo on the side of a building at its offices in Silicon Valley."><div>Source: Sundry Photography / Shutterstock.com</div></div>Although Sony (NYSE:<a href="https://investorplace.com/stock-quotes/sony-stock-quote/">SONY</a>) is not famous for holographic displays, the company has been focusing on developing different display technologies related to the holographic concept of visualization.&nbsp;



Sony&rsquo;s most notable contribution to holographic-like displays is their <a href="https://pro.sony/ue_US/products/spatial-reality-displays/3d-professional-images">Spatial Reality Display</a>. This device creates highly realistic 3D content that is viewable with the naked eye without special glasses. Besides display technology, the company also produces image sensors, which are very important for AR and VR devices. Therefore, it prepares them for future advancements in holographic and 3D display technologies.



Of course, SONY is a well-known blue-chip brand. However, despite its 100 billion market cap, analysts believe that its stock price will increase <a href="https://stockanalysis.com/stocks/sony/forecast/">appreciably</a> over the next twelve months, at 27.92%. EPS and revenue improvements are also on the horizon. This makes SONY one of those holographic display stocks to buy.



On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/08/the-3-best-holographic-display-stocks-to-buy-now/">The 3 Best Holographic Display Stocks to Buy Now</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The 3 Best Holographic Display Stocks to Buy Now

Robotaxi disruption: Tesla, Waymo, China, suppliers, and a potential flaw in the Death Star

LiDAR Quarterly Insights Q2 2024 Summary

ABNB

AEVA

AMZN

APTV

BIDU

CPTN

GOOG

HSAI

HSDT

HYMTF

INVZ

LAZR

MBLY

NAAS

PIII

PLUG

POAI

SBFM

SKLZ

SONY

SPCE

TSLA

UBER

VUZI

Press Releases

MicroVision to Announce Fourth Quarter and Full Year 2023 Results on February 28, 2024

MicroVision Announces Fourth Quarter and Full Year 2023 Results

MicroVision Announces $150 Million At-The-Market Equity Facility

Vuzix Corporation (NASDAQ: VUZI) Revolutionizing the Supply Chain with AR and Strategic Partnerships

Harnessing AR in Logistics: Vuzix's (NASDAQ: VUZI) Smart Glasses Revolutionize Warehouse Operations

MicroVision to Announce First Quarter 2024 Results on May 9, 2024

MicroVision Announces First Quarter 2024 Results

MicroVision Management to Participate in Deutsche Bank's Global Auto Industry Conference on June 11 and 12, 2024

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Microvision

Microvision (MVIS) Forecast

Microvision (NASDAQ:MVIS) Stock, Quote.Headers.trade-ideas